Vécsei P V, Kircher K, Nagel G, Toma-Bstaendig S, Ruhswurm I, Georgopoulos M, Zehetmayer M
Department of Ophthalmology, University of Vienna Medical School, Vienna, Austria.
Br J Ophthalmol. 1999 Dec;83(12):1324-8. doi: 10.1136/bjo.83.12.1324.
To evaluate the effect of high dose stereotactic radiotherapy on the ocular blood flow of patients with uveal melanoma.
Colour Doppler imaging (CDI) was used to measure blood flow velocity and vascular resistance in the ophthalmic, short posterior, and central retinal arteries of nine patients suffering from uveal melanoma. The measurements were taken before, 6 months, 1 year, and 2 years after stereotactic radiotherapy. Irradiation was performed with the Leksell gamma knife with the 59 (41-66.5) Gy total marginal dose divided in two equal fractions. CDI results were compared with age and sex matched healthy control eyes.
At each time of measurement, blood flow velocity in the central retinal artery of the affected eyes was significantly reduced whereas vascular resistance was only increased at the 2 year follow up. Blood flow velocity and vascular resistance in the short posterior arteries of melanoma eyes were also only significantly altered at the 2 year follow up. Blood flow velocity and vascular resistance in the ophthalmic artery of melanoma eyes were not changed at all follow ups.
In the melanoma eyes, blood flow velocity in the central retinal artery is reduced. High dose stereotactic radiotherapy with the Leksell gamma knife and a 59 (41-66.5) Gy total marginal dose in two fractions leads to a significant reduction of blood flow and a significant increase in resistance variables in the small ocular arteries within 2 years.
评估高剂量立体定向放射治疗对葡萄膜黑色素瘤患者眼血流的影响。
采用彩色多普勒成像(CDI)测量9例葡萄膜黑色素瘤患者眼动脉、视网膜后短动脉和视网膜中央动脉的血流速度和血管阻力。在立体定向放射治疗前、治疗后6个月、1年和2年进行测量。使用Leksell伽玛刀进行照射,总边缘剂量为59(41 - 66.5)Gy,分两个相等的部分给予。将CDI结果与年龄和性别匹配的健康对照眼进行比较。
在每次测量时,患眼视网膜中央动脉的血流速度显著降低,而血管阻力仅在2年随访时增加。黑色素瘤眼视网膜后短动脉的血流速度和血管阻力也仅在2年随访时发生显著变化。黑色素瘤眼眼动脉的血流速度和血管阻力在所有随访中均未改变。
在黑色素瘤眼中,视网膜中央动脉的血流速度降低。使用Leksell伽玛刀进行高剂量立体定向放射治疗,总边缘剂量为59(41 - 66.5)Gy,分两部分给予,在2年内可导致眼小动脉血流显著减少,阻力变量显著增加。